ANGELINI, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.948
AS - Asia 6.340
EU - Europa 5.023
SA - Sud America 274
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 11
Totale 46.654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.874
SG - Singapore 3.415
CN - Cina 1.663
HK - Hong Kong 814
IT - Italia 777
FI - Finlandia 750
SE - Svezia 635
FR - Francia 628
DE - Germania 587
RU - Federazione Russa 419
UA - Ucraina 418
GB - Regno Unito 377
VN - Vietnam 344
BR - Brasile 248
IE - Irlanda 188
NL - Olanda 66
CA - Canada 55
AT - Austria 46
IN - India 41
ES - Italia 22
CH - Svizzera 21
BE - Belgio 17
TR - Turchia 15
CI - Costa d'Avorio 13
MX - Messico 13
PL - Polonia 13
NO - Norvegia 12
ZA - Sudafrica 12
EU - Europa 11
AR - Argentina 9
RO - Romania 9
GR - Grecia 8
AU - Australia 7
BD - Bangladesh 7
VE - Venezuela 7
ID - Indonesia 5
LT - Lituania 5
MA - Marocco 5
CZ - Repubblica Ceca 4
IL - Israele 4
JP - Giappone 4
NZ - Nuova Zelanda 4
PE - Perù 4
SC - Seychelles 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
EG - Egitto 3
HU - Ungheria 3
IQ - Iraq 3
IR - Iran 3
KE - Kenya 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
DZ - Algeria 2
KR - Corea 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NG - Nigeria 2
PK - Pakistan 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
GA - Gabon 1
HR - Croazia 1
HT - Haiti 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
LB - Libano 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
TN - Tunisia 1
UY - Uruguay 1
Totale 46.654
Salva come PNG Salva come JPEG
Città #
Fairfield 5.550
Woodbridge 3.253
Houston 2.735
Chandler 2.243
Ashburn 2.210
Seattle 2.019
Ann Arbor 1.954
Wilmington 1.860
Cambridge 1.822
Jacksonville 1.822
Singapore 1.475
Princeton 1.057
Boardman 1.049
San Diego 856
Hong Kong 813
Medford 741
Roxbury 617
Santa Clara 520
Des Moines 447
Helsinki 393
Beijing 359
Dong Ket 342
Guangzhou 287
Nanjing 217
Menlo Park 166
Padova 148
New York 111
Shanghai 110
Ogden 99
Dublin 97
Norwalk 89
Hebei 81
London 69
Shenyang 69
Mountain View 59
Milan 54
Nanchang 53
Nuremberg 53
Tianjin 52
Columbus 49
Jiaxing 47
Kharkiv 40
Redwood City 39
Changsha 31
Las Vegas 30
Jinan 27
Borås 26
Rockville 26
Chicago 23
Arcugnano 22
Munich 22
Kilburn 20
Basking Ridge 19
São Paulo 19
Vigonza 19
Falls Church 18
Lappeenranta 18
Thiene 18
Vienna 18
Los Angeles 17
The Dalles 16
Charlottesville 14
Chiswick 14
Falkenstein 14
Rio de Janeiro 14
Washington 14
Zhengzhou 14
Abidjan 13
Dallas 13
Groningen 13
Frankfurt am Main 12
Indiana 12
Selvazzano Dentro 12
Toronto 12
Acton 11
Hounslow 11
Montréal 11
Ningbo 11
Tappahannock 11
Detroit 10
Morges 10
Rome 10
Belo Horizonte 9
Hefei 9
Lonigo 9
Monselice 9
Treviso 9
Buffalo 8
Hangzhou 8
Kunming 8
Mcallen 8
Prescot 8
Camponogara 7
Council Bluffs 7
Curtarolo 7
Madrid 7
Redmond 7
Turin 7
Brasília 6
Brussels 6
Totale 36.910
Salva come PNG Salva come JPEG
Nome #
Regulation of Endoplasmic Reticulum-Mitochondria contacts by Parkin via Mfn2 207
Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population 196
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 176
A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function. 174
Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants. 162
Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies 153
Parkinson-like features in ALS with predominant upper motor neuron involvement 153
ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion 148
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. 146
Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy 145
Cardioembolic stroke in Danon disease. 145
Progress in enzyme replacement therapy in glycogen storage disease type II 144
Functional changes in Becker muscular dystrophy: Implications for clinical trials in dystrophinopathies 142
Abnormal free radical homeostasis and oxphos activity in ALS muscle 140
Clinical phenotype, muscle MRI and muscle pathology of LGMD1F 140
Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2 138
TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. 137
A study on duplications of the dystrophin gene: Evidence of a geographical difference in the distribution of breakpoints by intron 137
PREVALENCE OF UNSUSPECTED MYOPATHY IN INFANTS PRESENTING FOR CLUBFOOT SURGERY 136
Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure. 135
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases 134
Carnitine and acyltransferase in experimental neurogenic atrophies: changes with treatment 134
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? 131
Metabolic myopathies: the challenge of new treatments 131
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy 130
Autophagy dysregulation in Danon disease 130
Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample 128
New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy 127
Acute quadriplegic myopathy in a 17 month old boy 127
The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia 126
Motor neuron disease in the Padua district of Italy: an epidemiological study 125
Radiological evidence of subclinical dysphagia in motor neuron disease 125
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 122
Dominant optic atrophy caused by a novel OPA1 mutation: Disruption of the mitochondrial network with preserved bioenergetics. 121
Myoclonus in mitochondrial disorders. 121
Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes 121
Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependency 121
Study of Muscle Autophagy and Atrophy Markers in Different Phenotypes of Pompe Disease 120
Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I 120
Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease 119
Decreased expression of DMPK: correlation with CTG repeat expansion and fibre type composition in myotonic dystrophy type 1 119
Optimization of respiratory chain enzymatic assays in muscle for the diagnosis of mitochondrial disorders. 119
Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients 118
Enzyme Replacement Therapy for Pompe Disease 118
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease 118
A mobile app for patients with Pompe disease and its possible clinical applications 118
Clinical and molecular characterization of limb girdle muscular dystrophy due to LAMA2 mutations. 117
Genetic epidemiology of myotonic dystrophy. 116
Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function 116
The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis 115
Reliability of the North Star Ambulatory Assessment in a multicentric setting 114
A study on duplications of the dystrophin gene: evidence of a geographical difference in the distribution of breakpoints by intron. 114
Familial ALS: clinical, genetic and morphological features. 114
Epidemiology of ALS in Padova district, Italy, from 1992 to 2005 114
MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. 113
Clinical and genetic characterization of an Italian family with slow-channel syndrome 112
Prevalence of dystrophin-positive fibers in 85 duchenne muscular dystrophy patients 111
Right hemisphere dysfunction and emotional processing in ALS: an fMRI study 110
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD). 110
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations 110
Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? 109
MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy 109
Hereditary spastic paraplegia associated with peripheral neuropathy: a distinct clinical and genetic entity 109
Gene expression profiling in dysferlinopathies using a dedicated muscle microarray 109
P. 5.7 Limb-girdle muscular dystrophy type 2E: Clinical, genetic and histopathological features of 27 European patients 108
Heart transplantation in patients with Inherited myopathies associated with end-stage cardiomyopathy: molecular and biochemical defects on cardiac and skeletal muscle 108
Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. 108
Exploring mental status in Friedreich's ataxia: a combined neuropsychological, behavioral and neuroimaging study. 107
Tubular aggregates: Sarcoplasmic reticulum origin, calcium storage ability, and functional implications 107
Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells. 107
“I have got something positive out of this situation”: psychological benefits of caregiving in relatives of young people with muscular dystrophy 106
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 106
[An] enumeration shall be made.. 106
CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis. 105
Population data on benign and severe forms of X-linked muscular dystrophy. 105
Therapeutic advances in the management of Pompe disease and other metabolic myopathies 105
Heart involvement in muscular dystrophies due to sarcoglycan gene mutations 104
Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facio-scapulo human muscular dystrophy. A potential target for pharmacological treatment? 104
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: Experience of the FSHD Italian National Registry 103
TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy 103
Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. 103
Cerebellar ataxia and coenzyme Q10 deficiency 102
Quality of life and motor impairment in ALS: Italian validation of ALSAQ 102
Sphingomonas paucimobilis associated with localised calf myositis 102
Micro-RNA expression in muscle and fiber morphometry in myotonic dystrophy type 1 102
Cardiac involvement in Becker muscular dystrophy 101
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation. 101
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 101
Esophageal motor function in patients with myotonic dystrophy 100
Dystrophin-positive fibers in duchenne dystrophy: Origin and correlation to clinical course 100
Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1 100
Redefining phenotypes associated with mitochondrial DNA single deletion 100
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 100
Screening for mutations in the muscle promoter region and for exonic deletions in a series of 115 DMD and BMD patients. 100
Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2) 100
Deflazacort in Duchenne dystrophy: study of long term effect 99
Memory deficits and retrieval processes in ALS 99
Telethon Network of Genetic Biobanks: a key service for diagnosis and research on rare diseases. 99
RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. 99
TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis 98
Totale 11.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 199.407
article - articoli 173.424
book - libri 128
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.731
Totale 375.690
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.102 0 0 0 0 0 0 0 0 0 561 277 264
2020/20219.978 102 267 106 4.390 489 544 93 824 1.258 531 824 550
2021/202211.265 246 1.088 1.015 2.071 497 496 350 1.309 355 176 1.151 2.511
2022/20235.224 1.636 480 68 548 721 633 14 321 530 28 201 44
2023/20242.736 82 291 210 153 130 187 132 121 243 310 417 460
2024/20257.855 28 1.063 761 473 1.632 243 496 1.124 1.704 331 0 0
Totale 47.685